The Wistar Institute
Philadelphia
About The Wistar Institute
The Wistar Institute offers biomedical research and translational science services focused on basic discovery, early-stage therapeutic development, and workforce training. Their portfolio includes a cancer research centre that integrates genome regulation, cell signalling, and oncogenesis; a vaccine and immunotherapy unit emphasising immunology, virology and immune-oncology; an HIV cure-and-viral-diseases centre targeting persistent infection and viral therapeutics; and a systems and computational biology core that supports large-scale data, modelling and shared resources. Wistar also delivers education and training programmes for high-school, undergraduate, graduate and post-doctoral scientists, and supports business-development collaborations to accelerate research into clinical and industry applications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Estimated revenue: $50K – $100K
- Total funding: $29.2M
- Funding stage: Seed
- Last round: Grant (Nov 2025)
- Website: wistar.org
- Phone: +1 (215) 898-3700
Industries & Categories
Biotechnology, Life Science, Medical, Non Profit
Social Profiles
Canonical: https://fsome.com/organization/the-wistar-institute-89687 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.